A Comprehensive Review of COVID-19 Virology, Vaccines, Variants, and Therapeutics

被引:178
作者
Forchette, Lauren [1 ]
Sebastian, William [1 ]
Liu, Tuoen [1 ]
机构
[1] West Virginia Sch Osteopath Med, Dept Biomed Sci, 400 Lee St North, Lewisburg, WV 24901 USA
关键词
severe acute respiratory syndrome coronavirus 2; coronavirus disease 2019; vaccines; variant strains; antiviral therapy; SARS-COV-2; NEUTRALIZATION; INFECTION; EFFICACY; BINDING;
D O I
10.1007/s11596-021-2395-1
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of the coronavirus disease 2019 (COVID-19), has caused more than 179 million infections and 3.8 million deaths worldwide. Throughout the past year, multiple vaccines have already been developed and used, while some others are in the process of being developed. However, the emergence of new mutant strains of SARS-CoV-2 that have demonstrated immune-evading characteristics and an increase in infective capabilities leads to potential ineffectiveness of the vaccines against these variants. The purpose of this review article is to highlight the current understanding of the immunological mechanisms of the virus and vaccines, as well as to investigate some key variants and mutations of the virus driving the current pandemic and their impacts on current management guidelines. We also discussed new technologies being developed for the prevention, treatment, and detection of SARS-CoV-2. In this paper, we thoroughly reviewed and provided crucial information on SARS-CoV-2 virology, vaccines and drugs being used and developed for its prevention and treatment, as well as important variant strains. Our review paper will be beneficial to health care professionals and researchers so they can have a better understanding of the basic sciences, prevention, and clinical treatment of COVID-19 during the pandemic. This paper consists of the most updated information that has been available as of June 21, 2021.
引用
收藏
页码:1037 / 1051
页数:15
相关论文
共 88 条
[31]  
Hoffmann Markus, 2020, bioRxiv, DOI [10.1016/j.ebiom.2021.103255, 10.1101/2020.08.05.237651]
[32]   Targeting inflammation and cytokine storm in COVID-19 [J].
Huang, Qianwen ;
Wu, Xiumei ;
Zheng, Xueying ;
Luo, Sihui ;
Xu, Suowen ;
Weng, Jianping .
PHARMACOLOGICAL RESEARCH, 2020, 159
[33]   COVID-19 mRNA vaccines [J].
Huang, Qinrui ;
Zeng, Jiawei ;
Yan, Jinghua .
JOURNAL OF GENETICS AND GENOMICS, 2021, 48 (02) :107-114
[34]   Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19 [J].
Huang, Yuan ;
Yang, Chan ;
Xu, Xin-feng ;
Xu, Wei ;
Liu, Shu-wen .
ACTA PHARMACOLOGICA SINICA, 2020, 41 (09) :1141-1149
[35]   Genetic comparison among various coronavirus strains for the identification of potential vaccine targets of SARS-CoV2 [J].
Kaur, Navpreet ;
Singh, Rimaljot ;
Dar, Zahid ;
Bijarnia, Rakesh Kumar ;
Dhingra, Neelima ;
Kaur, Tanzeer .
INFECTION GENETICS AND EVOLUTION, 2021, 89
[36]   Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection [J].
Khoury, David S. ;
Cromer, Deborah ;
Reynaldi, Arnold ;
Schlub, Timothy E. ;
Wheatley, Adam K. ;
Juno, Jennifer A. ;
Subbarao, Kanta ;
Kent, Stephen J. ;
Triccas, James A. ;
Davenport, Miles P. .
NATURE MEDICINE, 2021, 27 (07) :1205-+
[37]   Mechanism of SARS-CoV-2 polymerase stalling by remdesivir [J].
Kokic, Goran ;
Hillen, Hauke S. ;
Tegunov, Dimitry ;
Dienemann, Christian ;
Seitz, Florian ;
Schmitzova, Jana ;
Farnung, Lucas ;
Siewert, Aaron ;
Hoebartner, Claudia ;
Cramer, Patrick .
NATURE COMMUNICATIONS, 2021, 12 (01)
[38]   Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus [J].
Korber, Bette ;
Fischer, Will M. ;
Gnanakaran, Sandrasegaram ;
Yoon, Hyejin ;
Theiler, James ;
Abfalterer, Werner ;
Hengartner, Nick ;
Giorgi, Elena E. ;
Bhattacharya, Tanmoy ;
Foley, Brian ;
Hastie, Kathryn M. ;
Parker, Matthew D. ;
Partridge, David G. ;
Evans, Cariad M. ;
Freeman, Timothy M. ;
de Silva, Thushan, I ;
McDanal, Charlene ;
Perez, Lautaro G. ;
Tang, Haili ;
Moon-Walker, Alex ;
Whelan, Sean P. ;
LaBranche, Celia C. ;
Saphire, Erica O. ;
Montefiori, David C. .
CELL, 2020, 182 (04) :812-+
[39]   SARS-CoV-2 spike variants exhibit differential infectivity and neutralization resistance to convalescent or post-vaccination sera [J].
Kuzmina, Alona ;
Khalaila, Yara ;
Voloshin, Olga ;
Keren-Naus, Ayelet ;
Boehm-Cohen, Liora ;
Raviv, Yael ;
Shemer-Avni, Yonat ;
Rosenberg, Elli ;
Taube, Ran .
CELL HOST & MICROBE, 2021, 29 (04) :522-+
[40]   Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies [J].
Lee, Wen Shi ;
Wheatley, Adam K. ;
Kent, Stephen J. ;
DeKosky, Brandon J. .
NATURE MICROBIOLOGY, 2020, 5 (10) :1185-1191